Triglyceride Mix for Interference Testing

CAT:
952-C2010001
Size:
1 mL
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Triglyceride Mix for Interference Testing - image 1

Triglyceride Mix for Interference Testing

  • Description:

    Triglyceride mix for Interference Testing
    Catalog # C2010001
    Size 1 mL
    Other Names Triacylglycerols mix, triglycerides mix, triglycerides
    Storage -20C
    Concentration Neat
    Purity >95%
    Storage -20°C. Avoid repeated freeze/thaw cycles.
    Supplied as Liquid neat solution
    Buffer n/a
    Keywords Triglycerides, interference, endogenous substances, Tributyrin, Tricaproin, Tricaprylin, Tricaprin
     

    All Interference Products Brochure

    Interference Testing Brochure References Related to Triglyceride Mix
    • Gotto, A. M., and Paoletti, R. (1991). Triglycerides: the role in diabetes and atherosclerosis. New York: Raven Press.
    • Araujo, C., and Perez, D. (2013). Triglycerides: chemical structure, biosynthesis and role in disease. New York: Nova Science Publishers.
    • Geeraert, E., and Schepper, D. D. (1983). Structure elucidation of triglycerides by chromatographic techniques. Part 2: RP HPLC of triglycerides and brominated triglycerides. Journal of High Resolution Chromatography, 6(3), 123–132.
    • Medeiros, D. M., and Wildman, R. E. C. (2015). Advanced human nutrition. Burlington, MA: Jones & Bartlett Learning.
    • Gotto, A. M., and Paoletti, R. (1991). Triglycerides: the role in diabetes and atherosclerosis. New York: Raven Press.
    • Gilles A, Frechin L, Natchiar K, Biondani G, Loeffelholz OV, Holvec S, Malaval JL, Winum JY, Klaholz BP, Peyron JF. Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies. Cells. 2020 Mar 5;9(3). pii: E629.
    • EP07: Interference Testing in Clinical Chemistry. (2020). Retrieved from https://clsi.org/standards/products/method-evaluation/documents/ep07/.
    • Gilles A, Frechin L, Natchiar K, Biondani G, Loeffelholz OV, Holvec S, Malaval JL, Winum JY, Klaholz BP, Peyron JF. Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies. Cells. 2020 Mar 5;9(3). pii: E629.
    • Coussens NP, Auld D, Roby P, Walsh J, Baell JB, Kales S, Hadian K, Dahlin JL. Compound-Mediated Assay Interferences in Homogenous Proximity Assays. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-. 2020 Feb 1.
    Related Products https://moleculardepot.com/product/interference-test-kit-for-assay-validation/ https://moleculardepot.com/product/rheumatoid-factor-human-plasma/ https://moleculardepot.com/product/rheumatoid-factor-diluent/ https://moleculardepot.com/product/rheumatoid-factor-interference-blocker-rf/  
  • Short Description:

    Catalog #: C2010001 (1 mL)
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height:

    0.5
  • Height :

    0.5